Search

Streamlining Translation of Adverse Event Reports

Those involved in conducting multi-center clinical trials know that managing Adverse Event (AE) reports received from global trial sites can be very problematic, especially when the reports are in a different language, include handwritten notes and are re…
https://www.omnilingua.com/about/news-views/2018/04/streamlining-translation-adverse-event-reports

Our Partners:

GALA Logo ATA Logo TAUS

Ready to get started? Contact us today:

+1 319 365 8565 | info@omnilingua.com | Request a Quote

Big News from Ingenuiti

BIG NEWS FROM INGENUITI

Ingenuiti and its wholly-owned subsidiary OmniLingua will align and operate as one brand moving forward. As part of the brand alignment, a new website has been launched.

The new site is located at https://www.ingenuiti.com.

Moving forward, all the information regarding both companies can be found there, and this website will be closed on May 2nd, 2022.

You will be automatically redirected to the new site in 30 seconds.